| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/21/2015 | CN104302275A 类固醇反应性皮肤病的治疗方法 Treatment of steroid-responsive dermatosis |
| 01/21/2015 | CN104288786A 基于近红外量子点的肿瘤靶向诊疗系统及其制备方法 Diagnoses based tumor targeting and preparation method of near-infrared quantum dots |
| 01/21/2015 | CN104288785A 一种可用于局麻的组合物及其制备方法 The composition and preparation method can be used for local anesthesia |
| 01/21/2015 | CN104288772A 胆碱酯酶抑制剂和毒蕈碱受体阻断剂的联合应用 Combination of cholinesterase inhibitors and muscarinic receptor blocker |
| 01/21/2015 | CN104288771A α7nAChR激动剂的新用途 new uses α7nAChR agonists |
| 01/21/2015 | CN104288770A 受体激动剂的一种新用途 A new use of receptor agonist |
| 01/21/2015 | CN104288769A 一种西药外用膏剂及其制备方法 One kind of medicine topical ointment and its preparation method |
| 01/21/2015 | CN104288768A α2-肾上腺素能受体激动剂的用途 α2- adrenergic agonist use |
| 01/21/2015 | CN104288767A 治疗多巴胺相关疾病的植入剂 Treatment of dopamine-related diseases implants |
| 01/21/2015 | CN104288138A 含有硝基脂肪酸的营养制品 Nutritional products containing nitro fatty acids |
| 01/21/2015 | CN104288103A 用于制备纳米粒形式的生物活性化合物的方法 Methods for the preparation of biologically active compounds in the form of nanoparticles |
| 01/21/2015 | CN104288090A 具强化药物吸收效果载体 A strengthening of drug absorption carrier |
| 01/21/2015 | CN102724977B 富里酸与氟康唑或两性霉素b组合用于真菌感染的治疗 Fulvic acid treatment with fluconazole or amphotericin b combination for fungal infections |
| 01/21/2015 | CN102596202B 吡嘧司特的晶形 Pemirolast crystalline form |
| 01/21/2015 | CN102133196B 离子结合组合物 Ion binding composition |
| 01/20/2015 | US8937178 Phthalazinone compounds and methods for the treatment of cystic fibrosis |
| 01/20/2015 | US8937094 Triazole compounds that modulate HSP90 activity |
| 01/20/2015 | US8937093 Heterocyclic aspartyl protease inhibitors |
| 01/20/2015 | US8937088 Ureas for the treatment and prevention of cancer |
| 01/20/2015 | US8937069 Substituted pyrrolo[2,3-B]pyrazine compounds and their use |
| 01/20/2015 | US8937068 Pyridopyrazine derivatives and their use |
| 01/20/2015 | US8937063 Niacin mimetics, and methods of use thereof |
| 01/20/2015 | US8937059 Method for enhancing folding and transport of misfolded glucocerebrosidase |
| 01/20/2015 | US8937056 Multikinase inhibitors for use in the treatment of cancer |
| 01/20/2015 | US8937052 Therapeutic protocols using hyaluronan |
| 01/20/2015 | US8936815 Device for external use in alternative medicine applications |
| 01/20/2015 | US8936813 Spray drying methods and related compositions |
| 01/20/2015 | US8936812 Tamper-resistant oral opioid agonist formulations |
| 01/20/2015 | US8936808 Opioid agonist/opioid antagonist/acetaminophen combinations |
| 01/20/2015 | US8936804 Use of vanadium compounds to accelerate bone healing |
| 01/20/2015 | US8936784 Absorbable in situ gel-forming system, method of making and use thereof |
| 01/20/2015 | US8936781 Macrocyclic compounds as hepatitis C virus inhibitors |
| 01/20/2015 | CA2498000C Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 01/15/2015 | WO2015006508A2 Compositions and methods of screening for compounds that modulate activity at a tweak binding site on a crd of fn14 |
| 01/15/2015 | WO2015006287A2 Compositions prepared from poultry and methods of their use |
| 01/15/2015 | WO2015005901A1 Combinations of hepatitis c virus inhibitors |
| 01/15/2015 | WO2015005473A1 Method of predicting response of cancer to treatment |
| 01/15/2015 | WO2015005458A1 Glycosaminoglycan derivative and method for producing same |
| 01/15/2015 | WO2015005419A1 External-use composition producing foamed state upon use |
| 01/15/2015 | WO2015005305A1 Alxr agonist compound |
| 01/15/2015 | WO2015005248A1 Drug for treating/preventing allergic respiratory tract inflammation |
| 01/15/2015 | WO2015004089A1 Losmapimod for use in treating glomerular disease |
| 01/15/2015 | WO2015003623A1 Composition for treating osteoarthritis |
| 01/15/2015 | WO2015003411A1 Combined preparation and use thereof for preparing non-small cell lung cancer drug |
| 01/15/2015 | US20150018747 Methods and compositions to treat myocardial conditions |
| 01/15/2015 | US20150018428 Lutein/zeaxanthin for glare protection |
| 01/15/2015 | US20150018406 Modulation of breast cancer growth by modulation of xbp1 activity |
| 01/15/2015 | US20150018395 Chimeric small molecules for the recruitment of antibodies to cancer cells |
| 01/15/2015 | US20150018367 Aurora and flt3 kinases modulators |
| 01/15/2015 | US20150018353 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators |
| 01/15/2015 | US20150018340 Pipecolate-diketoamides for treatment of psychiatric disorders |
| 01/15/2015 | US20150018337 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 01/15/2015 | US20150018328 Therapeutically active compounds and their methods of use |
| 01/15/2015 | US20150018321 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 01/15/2015 | US20150018315 Novel tetra- and pentasubstituted benzimidazolium compounds |
| 01/15/2015 | US20150018314 Novel benzimidazolium compounds |
| 01/15/2015 | US20150018313 Novel 5-substituted benzimidazolium compounds |
| 01/15/2015 | US20150018312 Nitrogen containing compounds and their use |
| 01/15/2015 | US20150018300 Compounds |
| 01/15/2015 | US20150018298 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
| 01/15/2015 | US20150018295 Method for the preparation of triglycerides of medium-chain length fatty acids |
| 01/15/2015 | US20150018271 Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes |
| 01/15/2015 | US20150017267 Treatment of Inflammatory Disorders in Non-Human Mammals |
| 01/15/2015 | US20150017263 Fn14 antagonists and therapeutic uses thereof |
| 01/15/2015 | US20150017261 Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway |
| 01/15/2015 | US20150017259 Integrin interaction inhibitors for the treatment of cancer |
| 01/15/2015 | US20150017203 Combination product for treating excess weight and/or for improving the figure |
| 01/15/2015 | US20150017188 Cysteine engineered antibodies and conjugates |
| 01/15/2015 | US20150017186 Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use |
| 01/15/2015 | US20150017182 Methods for treating nasal polyposis by administering an il-4r antagonist |
| 01/15/2015 | US20150017176 Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor |
| 01/15/2015 | US20150017173 Antibodies to human transmembrane proteins |
| 01/15/2015 | US20150017172 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/15/2015 | US20150017171 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
| 01/15/2015 | US20150017170 Biomarker for selecting a subject for application of an anti-c-met antibody |
| 01/15/2015 | US20150017168 Dual variable domain immunoglobulins and uses thereof |
| 01/15/2015 | US20150017166 Regulation of glucose metabolism using anti-cgrp antibodies |
| 01/15/2015 | US20150017165 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF |
| 01/15/2015 | US20150017163 Methods for Treating or Preventing Ophthalmological Conditions |
| 01/15/2015 | US20150017157 Methods for treating acne |
| 01/15/2015 | US20150017154 Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 01/15/2015 | US20150017145 Pharmaceutical Kits Comprising Mesenchymal Stem Cells |
| 01/15/2015 | US20150017143 Composition comprising specific lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms |
| 01/15/2015 | US20150017140 Organoids comprising decellularized and repopulated placental vascular scaffold |
| 01/15/2015 | US20150017099 Diagnosis and treatment for respiratory tract diseases |
| 01/15/2015 | US20150017091 Detection and treatment of metastatic disease |
| 01/14/2015 | EP2824181A1 Novel fgfr3 fusion product |
| 01/14/2015 | EP2823829A1 Fibrin compositions containing strontium compounds for use in bone growth |
| 01/14/2015 | EP2823817A1 New compositions for treating CMT and related disorders |
| 01/14/2015 | EP2823812A1 Dipeptidylpeptidase IV inhibitors for use in the treatment of Type II diabetes |
| 01/14/2015 | EP2822595A1 Use of sphingosine-1 -phosphate receptors modulators for improving vaccine immunization |
| 01/14/2015 | EP2822588A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 01/14/2015 | EP2822551A1 Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| 01/14/2015 | DE202012013111U1 Eine Kombination aus mindestens zwei dirkt wirkenden antiviralen Wirkstoffen zur Verwendung in der Behandlung von HCV A combination of at least two dirkt acting antiviral agents for use in the treatment of HCV |
| 01/14/2015 | CN104284661A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和水杨酸组分的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and pharmaceutical compositions of the salicylic acid component |
| 01/14/2015 | CN104284660A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和NSAR的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and pharmaceutical compositions NSAR |
| 01/14/2015 | CN104284659A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和丙酸衍生物的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and pharmaceutical compositions of the propionic acid derivative |
| 01/14/2015 | CN104284658A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和加巴喷丁类的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and gabapentin pharmaceutical composition class D |
| 01/14/2015 | CN104284656A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和抗惊厥剂的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and anticonvulsant pharmaceutical composition |
| 01/14/2015 | CN104277117A 与磷脂酰丝氨酸结合的Fc融合构建体及其治疗用途 Phosphatidylserine bound Fc fusion constructs and therapeutic use |